Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Centessa Pharmaceuticals plc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- 0 vs. Q4 2022
- Shares held
- 66.9M
- +2.96M (+4.6%) vs. Q4 2022
- Total value
- $257.5M
- +$63.2M (+32.5%) vs. Q4 2022
- New holders
- 5
- 11 more added
- Sold out
- 5
- 11 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 70 | $0 | 0.00% | −55−44.0% | Reduced |
| Crewe Advisors LLC | 220 | $847 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 211 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 601 | $2.31K | 0.00% | −67−10.0% | Reduced |
| China Universal Asset Management Co., Ltd. | 712 | $2.74K | 0.00% | +179+33.6% | Added |
| Global Retirement Partners, LLC | 700 | $3.04K | 0.00% | 00.0% | Unchanged |
| Adirondack Trust Co | 925 | $3.56K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,285 | $4.95K | 0.00% | −707−35.5% | Reduced |
| Advisor Group Holdings, Inc. | 2,745 | $10.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,163 | $19.9K | 0.00% | +2,577+99.7% | Added |
| Compagnie Lombard Odier SCmA | 5,820 | $22.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6,400 | $24.6K | 0.00% | +6,400 | New |
| Tower Research Capital LLC (TRC) | 8,574 | $33.0K | 0.00% | −7,597−47.0% | Reduced |
| Goldman Sachs Group Inc | 10,960 | $42.2K | 0.00% | −4,033−26.9% | Reduced |
| Susquehanna International Group, LLP | 12,616 | $48.6K | 0.00% | +12,616 | New |
| Renaissance Technologies LLC | 15,700 | $60.0K | 0.00% | +15,700 | New |
| Geode Capital Management, LLC | 22,686 | $87.3K | 0.00% | +9,258+68.9% | Added |
| Jane Street Group, LLC | 40,238 | $154.9K | 0.00% | +14,253+54.9% | Added |
| Manufacturers Life Insurance Company, The | 57,421 | $221.1K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 82,055 | $315.9K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 99,225 | $382.0K | 0.00% | +86,478+678.4% | Added |
| Ensign Peak Advisors, Inc | 125,157 | $481.9K | 0.00% | −123,071−49.6% | Reduced |
| BlackRock Inc. | 292,660 | $1.13M | 0.00% | −17,381−5.6% | Reduced |
| Sio Capital Management, LLC | 347,869 | $1.34M | 0.66% | +347,869 | New |
| Octagon Capital Advisors LP | 396,000 | $1.52M | 0.22% | +396,000 | New |
| American Century Companies Inc | 514,116 | $1.97M | 0.00% | −312−0.1% | Reduced |
| Cormorant Asset Management, LP | 561,600 | $2.16M | 0.14% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 684,127 | $2.63M | 1.01% | +223,799+48.6% | Added |
| Kynam Capital Management, LP | 729,077 | $2.81M | 0.36% | −4,849−0.7% | Reduced |
| Woodline Partners LP | 735,993 | $2.83M | 0.04% | +516,573+235.4% | Added |
| Tanager Wealth Management LLP | 737,059 | $2.84M | 0.67% | −1,141,324−60.8% | Reduced |
| Morgan Stanley | 743,907 | $2.86M | 0.00% | +428,772+136.1% | Added |
| Franklin Resources Inc | 832,348 | $3.20M | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,230,909 | $4.74M | 0.00% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,251,137 | $4.82M | 0.24% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,693,736 | $6.52M | 1.35% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 1,775,482 | $6.84M | 0.02% | +1,695,782+2,127.7% | Added |
| Price T Rowe Associates Inc | 2,313,433 | $8.91M | 0.00% | −73,734−3.1% | Reduced |
| OUP Management Co., LLC | 2,937,615 | $11.3M | 22.57% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 3,931,818 | $15.1M | 20.71% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,618,779 | $21.6M | 0.70% | +386,500+7.4% | Added |
| BVF Inc | 9,423,215 | $36.3M | 1.33% | +2,528,870+36.7% | Added |
| General Atlantic LLC | 9,681,818 | $37.3M | 0.43% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $76.9M | 32.93% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −2,114,519−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −72,307−100.0% | Sold out |
| Tejara Capital Ltd | 0 | $0 | 0.00% | −42,235−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |